Here, we show that IRF3 is critical for controlling this process by acting as a brake to prevent hypertrophic obesity, an underlying pathological alteration linked to the development of obesity-associated diseases including IR and T2D [30]. Here, IRF3 is linked to type 2 diabetes mellitus.